Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021;17(5):e230421189012.
doi: 10.2174/1573403X16999201210195455.

State-of-the-Art Review of Current Therapies for HFpEF: An Overview of Interatrial Septal Device Therapy in Heart Failure

Affiliations
Review

State-of-the-Art Review of Current Therapies for HFpEF: An Overview of Interatrial Septal Device Therapy in Heart Failure

Mohammed Al-Sadawi et al. Curr Cardiol Rev. 2021.

Abstract

Heart failure (HF) affects an increasing number of geriatric patients. The condition is classified according to whether the left ventricular ejection fraction (EF) is reduced or preserved. Many patients have heart failure with preserved ejection fraction (HFpEF) and face a shortage of effective therapeutic strategies. However, an emerging mechanical strategy for treatment is gaining momentum. Interatrial septal connection devices, i.e. V-wave device and Interatrial septal device, are new devices for patients with heart failure with preserved ejection fraction. We review the function of these systems and the data from the recent clinical trials. Interatrial septal connection device therapy provided favorable efficacy and safety profile applicable to a wide range of patients with HFpEF. However, the long-term effects of these devices on morbidity.

Keywords: IASD; Interatrial device; V-wave; device treatment for heart failure.; heart failure; heart failure with preserved ejection fraction.

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
A sketch of the interatrial shunt device.

References

    1. Díez-Villanueva P., Alfonso F. Heart failure in the elderly. J. Geriatr. Cardiol. 2016;13(2):115–117. - PMC - PubMed
    1. American Heart Association. Heart Disease and Stroke Statistics: 2005 Update. Dallas, Tex: American Heart Association; 2005.
    1. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., Bravata D.M., Dai S., Ford E.S., Fox C.S., Franco S., Fullerton H.J., Gillespie C., Hailpern S.M., Heit J.A., Howard V.J., Huffman M.D., Kissela B.M., Kittner S.J., Lackland D.T., Lichtman J.H., Lisabeth L.D., Magid D., Marcus G.M., Marelli A., Matchar D.B., McGuire D.K., Mohler E.R., Moy C.S., Mussolino M.E., Nichol G., Paynter N.P., Schreiner P.J., Sorlie P.D., Stein J., Turan T.N., Virani S.S., Wong N.D., Woo D., Turner M.B. Heart disease and stroke statistics-2013 update: A report from the American Heart Association. Circulation. 2013;127(1):e6–e245. doi: 10.1161/CIR.0b013e31828124ad. - DOI - PMC - PubMed
    1. Nutter A.L., Tanawuttiwat T., Silver M.A. Evaluation of 6 prognostic models used to calculate mortality rates in elderly heart failure patients with a fatal heart failure admission. Congest. Heart Fail. 2010;16(5):196–201. doi: 10.1111/j.1751-7133.2010.00180.x. - DOI - PubMed
    1. Roger V.L. The heart failure epidemic. Int. J. Environ. Res. Public Health. 2010;7(4):1807–1830. doi: 10.3390/ijerph7041807. - DOI - PMC - PubMed